Reactive Molecules in Cigarette Smoke: Rethinking Cancer Therapy
BioTech · 27.06.2025 · 14 (3) · 52
DOI: 10.3390/biotech14030052 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift BioTech, online erschienen am 27.06.2025. Verfasst von Vehary Sakanyan. Beteiligte Einrichtung: Faculty of Biology, Faculty of Pharmacy, Nantes University, 44035 Nantes, France. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 82 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: the Agence Nationale de la Recherche, France, ProtNeteomix (Nantes, France), EIF Science Incubator (Yerevan, Armenia).
Abstract (Originalsprache)
Science has made significant progress in detecting reactive oxygen species (ROS) in tobacco smoke, which is an important step for precision cancer therapy. An important advance is also the understanding that superoxide can be produced by electrophilic molecules. The dual action of hydrogen peroxide, directly or via electrophilic molecules, in the development of oxidative stress allows for the identification of target proteins that can potentially stop unwanted signals in cancer development. However, despite advances in proteomics, reliable inhibitors to stop ROS-associated cancer progression have not yet been proposed for the treatment of tobacco cigarette smokers. This is likely due to an imperfect understanding of the diversity of molecular mechanisms of anti-ROS action. Fluorescent protein detection in living cells, called in-gel, offers a direct route to a better understanding of the rapid interaction of ROS and electrophilic compounds with targeted proteins. It seemed that the traditional paradigm of pharmaceutical innovation “one drug, one disease” did not solve the problem of tobacco smoking causing cancer. However, among the various therapeutic treatments for tobacco smokers, the best way to combat cancer today is smoking cessation, which fits into the “one-cure” paradigm.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Faculty of Biology, Faculty of Pharmacy, Nantes University, 44035 Nantes, France.
ORCID-Profile: Vehary Sakanyan
Förderung
- the Agence Nationale de la Recherche, France
- ProtNeteomix (Nantes, France)
- EIF Science Incubator (Yerevan, Armenia)
Zitieren
APA
Sakanyan, V. (2025). Reactive Molecules in Cigarette Smoke: Rethinking Cancer Therapy. BioTech, 14(3), 52. https://doi.org/10.3390/biotech14030052
Vancouver
Sakanyan V. Reactive Molecules in Cigarette Smoke: Rethinking Cancer Therapy. BioTech. 2025;14(3):52. doi:10.3390/biotech14030052
BibTeX
@article{Sakanyan2025,
author = {Sakanyan, Vehary},
title = {Reactive Molecules in Cigarette Smoke: Rethinking Cancer Therapy},
journal = {BioTech},
year = {2025},
volume = {14},
number = {3},
pages = {52},
doi = {10.3390/biotech14030052}
}
EUVIMED